This is a non-core endpoint: only basic statistics are computed.
Melanoma in situ of lower limb, including hip
DOID EFO MESH SNOMED Endpoint Browser
CD2_INSITU_MELANOMA_LOWERLIMB
melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
152
Check minimum number of events None
152
Include endpoints None
152
Remove individuals based on genotype QC
147
CD2_INSITU_MELANOMA_LOWERLIMB
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D03
Name in latin
Melanoma in situ coxae
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Melanoma in situ of lower limb, including hip
based on the number of shared cases.
Broader endpoints:
- Melanoma in situ of lower limb, including hip (controls excluding all cancers)
- Melanoma in situ
- Melanoma in situ (controls excluding all cancers)
- Malignant melanoma
- Malignant melanoma (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 147 | 110 | 37 |
| Unadjusted prevalence (%) | 0.04 | 0.05 | 0.02 |
| Mean age at first event (years) | 61.89 | 60.50 | 66.01 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INSITU_MELANOMA_LOWERLIMB – Melanoma in situ of lower limb, including hip
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Melanoma in situ of lower limb, including hip
↥Endpoint not on priority list, no data to show.